Phenylethylamine in the CNS: effects of monoamine oxidase inhibiting drugs, deuterium substitution and lesions and its role in the neuromodulation of catecholaminergic neurotransmission.
about
Anatomical and functional evidence for trace amines as unique modulators of locomotor function in the mammalian spinal cordTrace amine-associated receptor 1-Family archetype or iconoclast?A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion.Decreased beta-phenylethylamine in CSF in Parkinson's disease.Plasma Biomarkers for Monitoring Brain Pathophysiology in FMR1 Premutation Carriers.Pharmacology of Rasagiline, a New MAO-B Inhibitor Drug for the Treatment of Parkinson's Disease with Neuroprotective Potential.
P2860
Phenylethylamine in the CNS: effects of monoamine oxidase inhibiting drugs, deuterium substitution and lesions and its role in the neuromodulation of catecholaminergic neurotransmission.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Phenylethylamine in the CNS: e ...... olaminergic neurotransmission.
@en
Phenylethylamine in the CNS: e ...... olaminergic neurotransmission.
@nl
type
label
Phenylethylamine in the CNS: e ...... olaminergic neurotransmission.
@en
Phenylethylamine in the CNS: e ...... olaminergic neurotransmission.
@nl
prefLabel
Phenylethylamine in the CNS: e ...... olaminergic neurotransmission.
@en
Phenylethylamine in the CNS: e ...... olaminergic neurotransmission.
@nl
P2093
P1476
Phenylethylamine in the CNS: e ...... olaminergic neurotransmission.
@en
P2093
Boulton AA
Paterson IA
P304
P577
1990-01-01T00:00:00Z